
|Articles|May 15, 2004
Imaging analysis quantifies benefit of drug on eyelid swelling
Boston-A study using a novel, objective method for quantifying eyelid swelling reinforces the benefit of olopatadine HCl 0.1% (Patanol, Alcon) for reducing eyelid swelling triggered by allergen exposure, said Mark B. Abelson, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis
4
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
5



























